Home/Filings/4/0001562180-24-000327
4//SEC Filing

Thomas Monica R. 4

Accession 0001562180-24-000327

CIK 0001560241other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 6:03 AM ET

Size

8.1 KB

Accession

0001562180-24-000327

Insider Transaction Report

Form 4
Period: 2024-01-03
Thomas Monica R.
General Counsel
Transactions
  • Award

    Stock Options (Right to Buy)

    2024-01-03+55,87555,875 total
    Exercise: $2.97Exp: 2034-01-03Common Stock (55,875 underlying)
  • Award

    Common Stock

    2024-01-03+27,97578,151 total
Footnotes (4)
  • [F1]Represents a restricted stock unit ("RSU") award that vests 25% on January 3, 2025 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
  • [F3]Represents (i) 176 shares of common stock; (ii) 50,000 RSUs from award granted on May 22, 2023; and (iii) 27,975 RSUs from award granted on January 3, 2024.
  • [F4]The shares underlying this option vest as to 25% of the shares on January 3, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Issuer

G1 Therapeutics, Inc.

CIK 0001560241

Entity typeother

Related Parties

1
  • filerCIK 0001978347

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:03 AM ET
Size
8.1 KB